The effect of lifestyle interventions in women with polyendocrine metabolic ovarian syndrome: A systematic review and meta-analysis
Open Access
- 23 September 2026
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (9) , e1004887
Abstract
Background: Lifestyle interventions are recommended as first-line treatment in polyendocrine metabolic ovarian syndrome (PMOS), but their effectiveness across various outcomes remains unclear. In this systematic review, we evaluate the effectiveness of lifestyle interventions on reproductive, anthropometric, and metabolic outcomes. Methods and findings: We searched Medline, EMBASE, All EBM, PsycInfo, and CINAHL to June 2026 for studies examining lifestyle intervention compared with minimal or no treatment (usual care) in PMOS. Meta-analyses were conducted using random-effects model to estimate pooled odd ratios (OR) with 95% confidence intervals (CI). We conducted subgroup analyses to evaluate differences by intervention type and duration, and by baseline body mass index (BMI). A total of 34 studies (1,871 participants) were included from the retrieved 1,798 publications. Women who participated in lifestyle interventions were more likely to achieve regular menstrual cycles OR 4.03 (95% CI [1.16, 14.05] I 2 = 73%, 5 studies, 237 women), and have reduced waist circumference mean difference (MD) −2.38 (95% CI [−4.68, −0.08] I 2 = 90%, 18 studies, 915 women), fasting glucose MD −0.13 (95% CI [−0.25, −0.02] I 2 = 86%, 22 studies, 1,045 women) and fasting insulin MD −6.08 (95% CI [−9.86, −2.30] I 2 = 71%, 18 studies, 824 women) compared to women who had minimal or no treatment. Subgroup analyses showed that diet interventions had greater effect on reducing fasting glucose levels while exercise was most effective at reducing waist circumference and fasting insulin. In women with PMOS who were overweight or obese, lifestyle interventions led to greater reduction in weight, waist/hip ratio, fasting glucose, fasting insulin, total testosterone, total cholesterol, and low-density lipoprotein. The main limitation of this review is the high between-study heterogeneity in pooled estimates across many of the outcomes. Conclusion: Our review found that lifestyle interventions were associated with improved menstrual regularity and metabolic outcomes in women with PMOS, suggesting complementary benefits as no single intervention showed overall superiority. These findings support international recommendations, which endorse lifestyle interventions as first-line treatment, tailored to individual needs.Keywords
Funding Information
- Birmingham Biomedical Research Centre
- Australian National Health and Medical Research Council
- Australian National Health and Medical Research Council
- National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast
- Australian National Health and Medical Research Council
This publication has 46 references indexed in Scilit:
- Effects of carbohydrate reduced diet associated with strength training on clinical signs of women with polycystic ovary syndrome: Randomized clinical trialNutrition, 2025
- When one size does not fit all: Reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatmentsEndocrine and Metabolic Science, 2024
- Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndromeJournal of Endocrinological Investigation, 2022
- The effects of aerobic physical exercises on body image among women with polycystic ovary syndromeJournal of Affective Disorders, 2020
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypesFertility and Sterility, 2010
- The management of insulin resistance in polycystic ovary syndromeTrends in Endocrinology & Metabolism, 2007
- Molecular mechanisms of insulin resistance in polycystic ovary syndromeTrends in Molecular Medicine, 2006
- A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: A pilot studyFertility and Sterility, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory womenFertility and Sterility, 1994